All News

From an economic perspective, C. difficile has a staggering financial impact on the US health care system, as well on the patients infected.

In a study, 92.5% of patients treated with the 6-month regimen of Invega and 95% of patients treated with the 3-month regimen were relapse-free at 12 months.

Diabetic kidney disease develops in nearly 40% of patients with diabetes and serves as the leading cause of chronic kidney disease worldwide, according to the study.

RSV is defined as a seasonal illness that starts in the fall months and peaks during the winter when other respiratory illnesses are more common.

As specialty drugs move through clinical trials and preparations for commercialization begin, significant attention is warranted to this process considering the massive investments that would have been already made in the product up to this point.

Unlike other medications for chronic idiopathic constipation, prucalopride works by enhancing colonic peristalsis to increase bowel motility.

Treatment-emergent serious adverse events were reported more frequently in patients with PVD, which was likely due to their more advanced disease, according to the researchers.

Ten quiz questions to assess your knowledge on common symptoms and treatments for shingles.

During the trial, the research team wanted to look at aggressive B cell lymphomas and the outcomes comparing white patients versus minorities.

Guarding against external air pollution while reducing the risk of infection when driving presents a challenge.

Peter Koshland, PharmD, CEO of Koshland Pharm and a practicing pharmacist, discusses whether the process may be similar in the future in terms of compounding pharmacies’ role in the administration of psychedelic drugs like psilocybin.

Harry Webster, RPh, a registered pharmacist at Walgreens and a member of the LGBTQIA+ community, discusses the impact of stigma associated with PrEP and HIV on patients seeking to treat or prevent HIV.

Michael Ganio, PharmD, MS, BCPS, FASHP, Senior Director of Pharmacy Practice and Quality at the American Society of Health-System Pharmacists, discussed the recent strains for hospitals due to the newest wave of COVID-19.

Convalescent plasma, IVIG, and remdesivir have successfully helped immunocompromised patients recover from the virus.

Irritable bowel syndrome is the term for symptoms that occur when the contents of the large intestine move too quickly or too slowly.

The results of a new study show that stopping jailing individuals may be linked to benefits to community-wide and global public health.

Peter Koshland, PharmD, CEO of Koshland Pharm and a practicing pharmacist, discusses how compounding pharmacies manage quality assurance when putting together ketamine dosages for patients.

The nasal spray bypasses the gut and potential absorption issues associated with it, and offers consistent relief even when administered hours after the onset of a migraine attack.

New evidence shows that moving to urban areas in the Midwest or either coast could increase the longevity of an individual’s life.

Research shows that individuals who had either a severe or mild case of the virus had an increased risk of kidney damage and disease.

Study shows the benefit of green and blue spaces for individuals with COPD living in urban communities.

As pharmacists were pulled into patient-facing roles, many hospitals were forced to scale back or make adjustments in medication compounding practices.

The guidance noted it is preferable for immunocompromised patients to receive their third dose in a health care delivery setting rather than a pharmacy or public vaccination clinic.

COVID-19 convalescent plasma administered within the first week of symptoms did not prevent disease progression in a high-risk group of outpatients.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

A greater proportion of atogepant-treated participants achieved at least a 50% reduction in mean monthly migraine days.

Study suggests that lack of sleep in the first 6 months following childbirth can add between 3 and 7 years to the mother’s biological age.

Kidney disease is among the most common causes of both hyperkalemia and hypokalemia.